510(K) CLEARANCES 51 ▲2RECALLS POSTED 25 ▲2CLASS I 1PMA DECISIONS 50 ▲13WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K940159Substantially Equivalent

Cedia Dau Benzodiazepine Assay

Microgenics Corporation, Concord CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K940159 is the FDA 510(k) clearance record for CEDIA DAU BENZODIAZEPINE ASSAY, a class II device, cleared for Microgenics Corp. on under FDA product code JXM (Enzyme Immunoassay, Benzodiazepine). FDA records list 128 510(k) clearances for Microgenics Corp., from to . As of , FDA records show no recalls naming K940159.

Clearance record

Decision date
Received
(135 days to decision)
Product code
JXM Enzyme Immunoassay, Benzodiazepine
Regulation
21 CFR 862.3170
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Microgenics Corp. 2380a Bisso Ln., Concord CA
510(k) summary
Summary
Third party review
No

Clearances, product code JXM

Trailing 12 months

FDA records hold no clearances under product code JXM in the trailing twelve months.

FDA records show no clearances under product code JXM in the twelve months to November 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JXM, trailing twelve months
MonthClearances
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260
November 20260